drugset / Trial / NCT01436500
Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
A study of ifetroban in the treatment of hepatorenal syndrome (HRS) in hospitalized adult patients to assess the safety and pharmacokinetics of 3 days of intravenous ifetroban.
Timeline
- Start
- 2011-10
- Primary completion
- 2015-06
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ifetroban | Small molecule | 5 mg | Intravenous |
| Subject | Ifetroban | Small molecule | 15 mg | Intravenous |
| Subject | Ifetroban | Small molecule | 50 mg | Intravenous |
| Subject | Ifetroban | Small molecule | 150 mg | Intravenous |